Osteosarcoma progression is associated with increased nuclear levels and transcriptional activity of activated β-Catenin

Osteosarcoma (OS) is an aggressive primary bone malignancy that has peak incidence in children and young adults <25 years of age. Despite current multimodal treatments, no significant change in patient outcome has been observed in two decades. Presently, there is a lack of established, reliable b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Noureen, Venkateswaran, Geetha, Garcia, Elizabeth, Landry, Takaaki, McColl, Hunter, Sergi, Consolato, Persad, Amit, Abuetabh, Yasser, Eisenstat, David D., Persad, Sujata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584208/
https://www.ncbi.nlm.nih.gov/pubmed/31258833
http://dx.doi.org/10.18632/genesandcancer.191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584208/
https://www.ncbi.nlm.nih.gov/pubmed/31258833
http://dx.doi.org/10.18632/genesandcancer.191

Ejemplares similares